MEDP Maintained by BMO Capital -- Price Target Raised to $670

gurufocus.com · 2026-10-26

Medpace Holdings (MEDP) Analyst Rating Update On October 23, 2026, BMO Capital maintained a "Market Perform" rating for Medpace Holdings (MEDP) while raising

TickrTrends take: BMO Capital's price target increase to $670 occurs within a context where TickrTrends currently assesses MEDP as overvalued according to its derived valuation metrics. For investors focused on valuation dynamics, the gap between analyst price targets and current valuation assessments warrants monitoring, particularly given the Healthcare sector's sensitivity to both fundamental performance and multiple compression. The maintained rating combined with a raised target suggests analyst conviction in the company's trajectory, though this should be evaluated against whether MEDP's current trading levels align with or diverge from its intrinsic value metrics.

Read the full story at gurufocus.com →